The Health Care M&A Monthly: Bristol-Myers Squibb Builds a Bridge to New Revenues
After some weeks of speculation in the press, Bristol-Myers Squibb (NYSE: BMY) finally announced it would buy The DuPont Pharmaceutical Company, a subsidiary of E. I. Du Pont De Nemours (NYSE: DD), for $7.8 billion in cash. This deal advances both companies’ plans to...The Health Care M&A Monthly: The Second Quarter Health Care M&A Market
The health care industry saw a total of 263 mergers and acquisitions announced during the second quarter of 2006, up 11% from the 236 transactions announced in the prior quarter, Q1:06 and up 15% from the 228 deals announced in the year-ago quarter, Q2:05. The four...The Health Care M&A Monthly: Pharma Deals Target Consumer Health And Generic Drug Markets
Email Editor Last month’s gossip has become this month’s headline news. Two rumors in the pharma industry, which were noted in last month’s issue, have now materialized as full-fledged deals. Both reflect the ongoing attractiveness of consumer products and generic...The Health Care M&A Monthly: $12.8 Billion Deal Unites Thermo Electron and Fisher Scientific
Email Editor Mega-deals, among their many attractions, are interesting because of the way they may change the landscape of an industry. By all rights, Thermo Electron Corporation’s (NYSE: TMO) proposed $12.8 billion acquisition of Fisher Scientific International, Inc....The Health Care M&A Monthly: Medical Device Merger Mania
Email Editor The month of April saw a surge of dealmaking in the Medical Device sector, with a total of 14 transactions announced. Based on revealed prices, the total amount spent to fund this activity was $4.7 billion, or 59% of all M&A dollars spent during the...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
